Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1994-08-15
1998-10-20
Caputa, Anthony C.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241421, 4241471, 4241591, 5303873, 53038815, 5303883, A61K 3942, C07K 1608
Patent
active
058243070
ABSTRACT:
This invention relates to a human antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody, against respiratory syncytial virus which is MAb1129 and the use thereof for the prevention and/or treatment of RSV infection.
REFERENCES:
patent: 4659563 (1987-04-01), Dobkin
patent: 4717766 (1988-01-01), Dobkin
patent: 4800078 (1989-01-01), Prince et al.
Tempest et al (1991, Mar.) Biotechnology 9:266-271.
Beeler et al (1989) J. Virol. 63(7):2941-2950.
Jones et al (1986) Nature 329:522-525.
Roitt (1991) "Essential Immunology", Blackwell Scientific Publications, Oxford, pp. 65-68 & 74.
Caputa Anthony C.
MedImmune, Inc.
Olstein Elliot M.
LandOfFree
Human-murine chimeric antibodies against respiratory syncytial v does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human-murine chimeric antibodies against respiratory syncytial v, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human-murine chimeric antibodies against respiratory syncytial v will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-241753